Government Relations News

White HouseWhat Will a Trump Administration Mean for Healthcare?

Initial analysis from JPA Health Communications.
Trying to understand what President-elect Trump will do about healthcare—an area in which he gave just one speech—is not easy.

more

FDABill Could Increase Patient Influence in Drug Development Process

Patients and advocacy groups may be one step closer to increasing the strength of their voices in the development of new treatments. 

more
 

Technology plays an important role in health empowerment.What's in a Name? The Scoop on Connected Health

While buzzwords like eHealth, telemedicine, wireless health and mobile health are grabbing the headlines, the driving force behind this intersection of health and technology is simple – it’s all about empowering people.

more

SCOTUS Watch: Supreme Court Rules Human Genes Cannot Be Patented

The Supreme Court unanimously voted today that genes isolated from the human body cannot be patented.

more
 

SCOTUS to hear arguments on gene patents, Photo c2012, Chris Potter, FlickrSCOTUS Watch: Justices to Hear Arguments on Legality of Gene Patents Today

Gene patents have become a deeply divisive issue among medical and research communities. Today, SCOTUS will hear arguments for Association for Molecular Pathology v. Myriad Genetics, Inc.

more

All Eyes on Massachusetts for Health ReformImplementing Healthcare Reform: Eyes on Massachusetts

As a state that’s setting the bar for implementation of healthcare reform, the response of Massachusetts providers and insurers to new healthcare regulation will send a clear message to state and federal legislators about what works (and what doesn’t work) in efforts to reduce rising healthcare costs.

more
 

Supreme Court Ruling: Implications for Health CommunicationSupreme Court Ruling: Implications for Health Communication

Earlier today, the United States Supreme Court ruled 5-4 to uphold the hotly-debated Affordable Care Act as constitutional.

more

pillsHouse Votes to Expand FDA Power to Tackle Drug Shortages, Reauthorizes Pharma Industry Fees

In a rare instance of bipartisan cooperation between lawmakers on the Hill, the U.S. House of Representatives voted 387-5 on Wednesday in support of legislation that – if passed into law – would give the Food and Drug Administration (FDA) increased powers to tackle critical drug shortages.

more